Newbury Pharmaceuticals is a rapidly growing hybrid pharmaceutical company with a primary focus on the Nordic region, complemented by selective international sales. We combine the capabilities of a marketing authorization holder with the flexibility of a specialized commercial partner, offering a portfolio that spans several therapeutic areas. Our model includes both in-licensed products and brands for which we act as the exclusive distributor and local representative.

As a strong regional player, we offer an attractive alternative to large multinational organizations. Our mission is to ensure that high-quality, value-creating medicines and technologies reach patients across the Nordics.

Our culture is built on deep expertise, openness, and curiosity. We believe in high performance while recognizing that a healthy work–life balance is essential for sustainable success. Collaboration, transparency, and continuous learning define how we operate.

Newbury Pharmaceuticals continues to broaden its portfolio through global partnerships. Our current product range is diverse, and over time we plan to grow our footprint in specialty and branded medicines in areas where we can contribute meaningful value for patients, healthcare professionals, and society.

With strong regional market knowledge, international reach, and operational excellence across regulatory affairs, market access, supply chain, and commercialization, Newbury strives to make a meaningful and lasting impact on healthcare.